UBS Group
ASPN icon

UBS Group’s Aspen Aerogels ASPN Stock Holding History

UBS Group’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$647K Sell
189,229
-126,119
-40% -$425K ﹤0.01% 5885
2025
Q4 		$892K Sell
315,348
-81,461
-21% -$420K ﹤0.01% 5673
2025
Q3 		$2.76M Buy
396,809
+123,980
+45% +$874K ﹤0.01% 4660
2025
Q2 		$1.62M Sell
272,829
-147,559
-35% -$849K ﹤0.01% 5024
2025
Q1 		$2.69M Sell
420,388
-15,455
-4% -$149K ﹤0.01% 4429
2024
Q4 		$5.18M Buy
435,843
+304,592
+232% +$5.19M ﹤0.01% 3812
2024
Q3 		$3.63M Sell
131,251
-2,432
-2% -$60.8K ﹤0.01% 3393
2024
Q2 		$3.19M Sell
133,683
-166,348
-55% -$3.9M ﹤0.01% 3288
2024
Q1 		$5.28M Buy
300,031
+94,214
+46% +$1.39M ﹤0.01% 2911
2023
Q4 		$3.25M Buy
205,817
+24,413
+13% +$252K ﹤0.01% 3266
2023
Q3 		$1.56M Buy
181,404
+2,950
+2% +$21K ﹤0.01% 3693
2023
Q2 		$1.41M Buy
178,454
+15,834
+10% +$110K ﹤0.01% 3897
2023
Q1 		$1.21M Buy
162,620
+47,096
+41% +$468K ﹤0.01% 3935
2022
Q4 		$1.36M Buy
115,524
+47,559
+70% +$544K ﹤0.01% 3774
2022
Q3 		$627K Sell
67,965
-3,147
-4% -$38.1K ﹤0.01% 4145
2022
Q2 		$703K Buy
71,112
+2,334
+3% +$47.1K ﹤0.01% 4006
2022
Q1 		$2.37M Sell
68,778
-26,177
-28% -$850K ﹤0.01% 3272
2021
Q4 		$4.73M Buy
94,955
+11,452
+14% +$603K ﹤0.01% 2884
2021
Q3 		$3.84M Buy
83,503
+393
+0.5% +$15.6K ﹤0.01% 2955
2021
Q2 		$2.49M Buy
83,110
+56,937
+218% +$1.16M ﹤0.01% 3378
2021
Q1 		$532K Sell
26,173
-22,739
-46% -$480K ﹤0.01% 4818
2020
Q4 		$817K Sell
48,912
-12,400
-20% -$163K ﹤0.01% 4182
2020
Q3 		$671K Buy
61,312
+54,329
+778% +$430K ﹤0.01% 3949
2020
Q2 		$46K Buy
6,983
+6,483
+1,297% +$41.6K ﹤0.01% 5912
2020
Q1 		$3K Buy
+500
New +$4.06K ﹤0.01% 7467
2019
Q2 		– Sell
-1,752
Closed -$4K – 7843
2019
Q1 		$4K Buy
1,752
+1,001
+133% +$2.98K ﹤0.01% 7243
2018
Q4 		$2K Sell
751
-726
-49% -$2.46K ﹤0.01% 7785
2018
Q3 		$7K Buy
1,477
+120
+9% +$584 ﹤0.01% 7320
2018
Q2 		$7K Sell
1,357
-1,743
-56% -$8.28K ﹤0.01% 7314
2018
Q1 		$13K Buy
3,100
+1,750
+130% +$8.27K ﹤0.01% 6702
2017
Q4 		$7K Sell
1,350
-701
-34% -$3.27K ﹤0.01% 7210
2017
Q3 		$9K Sell
2,051
-2,205
-52% -$9.64K ﹤0.01% 6934
2017
Q2 		$19K Buy
4,256
+2,287
+116% +$9.65K ﹤0.01% 6331
2017
Q1 		$8K Sell
1,969
-1,316
-40% -$5.61K ﹤0.01% 6741
2016
Q4 		$14K Buy
3,285
+1,151
+54% +$5.61K ﹤0.01% 6717
2016
Q3 		$13K Sell
2,134
-1,863
-47% -$9.38K ﹤0.01% 6591
2016
Q2 		$20K Buy
+3,997
New +$17.5K ﹤0.01% 6301
2015
Q4 		– Sell
-925
Closed -$7K – 8320
2015
Q3 		$7K Buy
+925
New +$6.74K ﹤0.01% 7474
2015
Q1 		– Sell
-612
Closed -$5K – 8782
2014
Q4 		$5K Buy
+612
New +$5.19K ﹤0.01% 8945

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

UBS Group's ASPN Position: Q1 2026 in Review

UBS Group reduced its Aspen Aerogels (ASPN) stake by 40% in Q1 2026, selling an estimated $425K and leaving 189,229 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #5885.

UBS Group first reported a position in ASPN in Q4 2014 and has held it in 39 quarters since. The position peaked at $5.28M in Q1 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • UBS Group held 189,229 shares of Aspen Aerogels worth $647K as of Q1 2026.
  • UBS Group sold 126,119 Aspen Aerogels shares in Q1 2026, an estimated $425K.
  • Aspen Aerogels made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5885 holding.
  • UBS Group first reported a position in Aspen Aerogels in Q4 2014 and has held it in 39 quarters since.
  • UBS Group's Aspen Aerogels position peaked at $5.28M in Q1 2024.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.